These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15748597)

  • 1. Autoantibodies in Type 1 diabetes.
    Schmidt KD; Valeri C; Leslie RD
    Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.
    Villalba A; Iacono RF; Valdez SN; Poskus E
    Autoimmunity; 2008 Mar; 41(2):143-53. PubMed ID: 18324484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and prevention of type I diabetes.
    Eisenbarth GS; Gianani R; Pugliese A; Verge CF; Pietropaolo M
    Transplant Proc; 1994 Apr; 26(2):361-2. PubMed ID: 8171463
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibody markers for the diagnosis and prediction of type 1 diabetes.
    Wasserfall CH; Atkinson MA
    Autoimmun Rev; 2006 Jul; 5(6):424-8. PubMed ID: 16890898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 7. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
    Franke B; Galloway TS; Wilkin TJ
    Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
    Batstra MR; Aanstoot HJ; Herbrink P
    Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study.
    Brekke HK; Ludvigsson J
    Pediatr Diabetes; 2007 Feb; 8(1):11-4. PubMed ID: 17341286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
    Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
    Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and prevention of Type 1 diabetes mellitus.
    Zhang L; Eisenbarth GS
    J Diabetes; 2011 Mar; 3(1):48-57. PubMed ID: 21073664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
    Mandrup-Poulsen TR
    Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon.
    Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P
    Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
    Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
    Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation with human recombinant autoantigens.
    Lernmark A; Agardh CD
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of autoimmune diabetes mellitus].
    Amital-Teplizki H; Shoenfeld Y
    Harefuah; 1994 Feb; 126(4):211-4. PubMed ID: 8168767
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoantibodies against GAD, GAD65 and IA-2].
    Tsujii S
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.